HTRA1 Mutations Tied to Cerebral Small Vessel Disease

This article originally appeared here.
Share this content:
<i>HTRA1</i> Mutations Tied to Cerebral Small Vessel Disease
HTRA1 Mutations Tied to Cerebral Small Vessel Disease

FRIDAY, Aug. 11, 2017 (HealthDay News) -- Heterozygous HTRA1 mutations may play a role in familial cerebral small vessel disease (SVD), according to a study published online Aug. 6 in CNS Neuroscience & Therapeutics.

Ilaria Di Donato, M.D., from the University of Siena in Italy, and colleagues performed mutational analysis of HTRA1 gene in 142 NOTCH3-negative patients and 160 healthy age-matched controls.

The researchers found that five different HTRA1 heterozygous mutations were detected in nine patients from five unrelated families. In these patients, the clinical phenotype was typical of SVD, and the onset was pre-senile. A subcortical leukoencephalopathy, with involvement of the external and internal capsule, corpus callosum, and multiple lacunar infarcts, was seen on brain magnetic resonance imaging. Additionally, cerebral microbleeds were seen, but anterior temporal lobe involvement was not present.

"Our observation further supports the pathogenic role of the heterozygous HTRA1 mutations in familial SVD," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths